Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Executive Record

Joseph C. Papa

Chief executive: Emergent BioSolutions Inc. (21 Feb 2024 to present)

9commitments announced
8with a clear outcome
7met on time
–rate shown after 15 outcomes

Commitments are credited to the chief executive in office on the day they were announced. Where a deadline fell after the leader left, the entry is marked. Sources for each leadership change: Emergent BioSolutions Inc. filing.

Commitments announced under Joseph C. Papa

Emergent BioSolutions Inc.announced 11 Sep 2025 Begin deliveries of ACAM2000 vaccine to the U.S. government Not met30 Sep 2025
Emergent BioSolutions Inc.announced 7 May 2025 Deliver international medical countermeasure orders Met31 Dec 2025
Emergent BioSolutions Inc.announced 10 Mar 2025 Close the sale of the Baltimore-Bayview manufacturing site Met31 Mar 2025
Emergent BioSolutions Inc.announced 2 Jul 2024 Supply ACAM2000 smallpox vaccine Met31 Dec 2024
Emergent BioSolutions Inc.announced 2 Jul 2024 Supply CYFENDUS anthrax vaccine Met31 Dec 2024
Emergent BioSolutions Inc.announced 2 Jul 2024 Supply VIGIV and BAT drug products Being checked31 Mar 2025
Emergent BioSolutions Inc.announced 20 Jun 2024 Close the sale of the Baltimore-Camden manufacturing facility to Bora Pharmaceuticals Met30 Sep 2024
Emergent BioSolutions Inc.announced 1 May 2024 Shut down the Rockville, Maryland Drug Product facility Met31 Dec 2024
Emergent BioSolutions Inc.announced 1 May 2024 Shut down the Baltimore-Bayview Drug Substance manufacturing facility Met31 Dec 2024

Is this record wrong, or are you Joseph C. Papa? Add a statement or ask for a correction.

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.